Corporate calendar for Inovio Pharmaceuticals, Inc. (INO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2017-09-28 | $0.0057 | 1.98% |
| 2017-08-29 | $0.0057 | 1.98% |
| 2017-07-27 | $0.0057 | 1.98% |
| 2017-06-28 | $0.0057 | 1.98% |
Stock Splits
| Date | Ratio |
|---|---|
| 2024-01-25 | 1:12 |
| 2014-06-06 | 1:4 |
| 2004-09-13 | 1:4 |
Price
| Price | $1.15 |
| Market Cap | $79M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 9 |
| Hold | 6 |
| Sell | 2 |
| Strong Sell | 0 |
| Total analysts | 17 |
| Avg rating (1-5) | 0.41 |
Related companies: ABOS · ACTU · AGEN · ALEC · FATE · IRD · MCRB
Explore sector: Healthcare · Biotechnology
More sections of INO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks